Back to Authors

Owen, Charles

Mayo Clinic

Eli Lilly (United States)

Citations 1

P68 Mirikizumab versus placebo: histologic inflammation in 5 intestinal segments in randomized controlled phase 3 trial for crohn’s disease participants
Feagan, Brian G., Hisamatsu, Tadakazu , D’Haens, Geert , Pai, Rish K. , Lin, Zhantao, Protić, Marijana , Hon, Emily, Escobar, Rodrigo , Reinisch, Walter , Dhesi, Endip , Jairath, Vipul , Magro, Fernando , Hertogh, Gert D. , Harpaz, Noam , Morris, Nathan , Owen, Charles, Reinisch, Walter

Posters | June 23, 2025 | Volume: No volume available | Issue: No issue available | Pages: A129.2-A130

10.1136/gutjnl-2025-bsg.204 Get It